Clinical Trials Directory

Trials / Completed

CompletedNCT03603444

Reliability of Serum Calcium to Phosphorus (Ca/P) Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism

Serum Calcium to Phosphorus (Ca/P) Ratio to Define Disorders of Ca-P Metabolism

Status
Completed
Phase
Study type
Observational
Enrollment
606 (actual)
Sponsor
Azienda Ospedaliero-Universitaria di Modena · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

BACKGROUND: Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder. The Ca/P ratio is an accurate tool to differentiate patients with PHPT (\>3.5 if Ca and P are expressed in mg/dl) from healthy subjects. The reliability of this index is based on the fact that serum Ca and P are inversely related together. However, other disorders of the Ca-P metabolism, such as hypophosphoremia (HypoP) not related to PHPT, might also impair the Ca/P ratio. OBJECTIVE: To validate the accuracy of Ca/P ratio in the diagnosis of Ca-P metabolism disorders, including also patients with documented HypoP not related to PHPT. METHODS: A single-center, retrospective, case-control study will be carried out. Biochemical measurements will include parathormone (PTH), vitamin D, serum Ca and P, serum albumin and creatinine.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention are provided

Timeline

Start date
2011-01-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2018-07-27
Last updated
2018-07-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03603444. Inclusion in this directory is not an endorsement.